Daventry Group, LP - Q2 2023 holdings

$135 Million is the total value of Daventry Group, LP's 7 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 0.0% .

 Value Shares↓ Weighting
TENB SellTENABLE HLDGS INC$26,580,002
-8.6%
610,333
-0.3%
19.67%
-3.4%
PTC  PTC INC$22,135,050
+11.0%
155,5520.0%16.38%
+17.4%
HCAT  HEALTH CATALYST INC$20,463,888
+7.1%
1,637,1110.0%15.15%
+13.3%
NEWR BuyNEW RELIC INC$18,856,274
-12.3%
288,146
+0.9%
13.96%
-7.2%
ESTC SellELASTIC N V$16,429,147
-22.4%
256,225
-29.9%
12.16%
-17.9%
EVBG BuyEVERBRIDGE INC$15,582,686
-19.5%
579,282
+3.7%
11.53%
-14.9%
CRL BuyCHARLES RIV LABS INTL INC$15,058,736
+18.2%
71,623
+13.5%
11.15%
+25.1%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-11
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TENABLE HLDGS INC8Q3 202322.5%
ELASTIC N V8Q3 202317.5%
HEALTH CATALYST INC8Q3 202316.8%
PTC INC8Q3 202316.4%
EVERBRIDGE INC7Q3 202313.6%
NEW RELIC INC6Q3 202315.0%
OAK STR HEALTH INC5Q4 202217.6%
CHARLES RIV LABS INTL INC3Q3 202311.1%
SAILPOINT TECHNOLOGIES HLDGS2Q1 202223.2%
HASHICORP INC1Q3 202311.4%

View Daventry Group, LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-13
13F-HR2023-08-11
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-13
13F-HR2022-02-14

View Daventry Group, LP's complete filings history.

Export Daventry Group, LP's holdings